The Medicare Drug ‘Donut Hole’ is a Much Smaller Problem Than You Think
On Wednesday, I wrote about why closing the Medicare drug-benefit ‘donut hole’ is a terrible idea, one that some congressional Republicans are poised to endorse. In that post, I described why eliminating this key cost-sharing provision will destroy the program’s fiscal controls. Today I want to dig into the data about the Medicare drug program, and explain why the program’s inadequacies are…